Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xenoport Inc (NASDAQ:XNPT)

7.14
Delayed Data
As of Jul 30
 +0.02 / +0.28%
Today’s Change
4.12
Today|||52-Week Range
9.60
-18.59%
Year-to-Date
No recent news for Xenoport Inc.

Today’s Trading

Previous close7.12
Today’s open7.06
Day’s range-- - --
Volume412,613
Average volume (3 months)473,266
Market cap$447.0M
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)+55.25%
Earnings growth (this year)-58.44%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+489.46%
P/E ratioNM
Price/Sales11.39
Price/Book4.88

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...+0.15+1.60%
MRTXMirati Therapeutics ...+0.04+0.15%
PRTKParatek Pharmaceutic...-0.34-1.35%
ADMSAdamas Pharmaceutica...-0.44-1.73%
Data as of 07/30/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$46.9M
Annual profit (last year)-$49.3M
Net profit margin-105.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald W. Barrett
Chief Operating Officer &
Executive Vice President
Vincent J. Angotti
Corporate headquarters
Santa Clara, California

Forecasts